Skip to main content
Premium Trial:

Request an Annual Quote

Renishaw Dx Lands CE Mark for MDx System, Fungal Assay

NEW YORK (GenomeWeb) – Renishaw Diagnostics has announced that its RenDx Multiplex Assay System and Fungiplex assay have received CE-IVD certification.

The RenDx platform is an automated instrument that identifies 12 Candida and Aspergillus fungal species using a unique detection technology known as surface enhanced resonance Raman spectroscopy. The Fungiplex assay is a multiplex PCR-based in vitro test for the qualitative detection of Candida and Aspergillus DNA in blood samples.

"The extensive target menu for the Fungiplex assay, together with the high sensitivity that can be achieved through our exceptional detection technology, has the potential to aid earlier diagnosis, reduce overall spend, and improve patient outcomes for those susceptible to these life-threatening infections," Renishaw General Manager Rupert Jones said in a statement.

In 2013, UK-based Renishaw signed a collaborative agreement with MRC Technology to develop clinical diagnostic tests for infectious diseases.